Renal Stones in an Infant with Microcephaly and Spastic Quadriparesis: Answers
Overview
Overview
Journal
Pediatr Nephrol
Specialties
Nephrology
Pediatrics
Pediatrics
Date
2019 Dec 19
PMID
31848698
Citations
2
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Kinsinger M, Ivanisevic J, Mithal D BMC Med Genomics. 2024; 17(1):292.
PMID: 39695700 PMC: 11658218. DOI: 10.1186/s12920-024-02027-x.
Review of childhood genetic nephrolithiasis and nephrocalcinosis.
Gefen A, Zaritsky J Front Genet. 2024; 15:1381174.
PMID: 38606357 PMC: 11007102. DOI: 10.3389/fgene.2024.1381174.
References
1.
Jinnah H, Visser J, Harris J, Verdu A, Larovere L, Ceballos-Picot I
. Delineation of the motor disorder of Lesch-Nyhan disease. Brain. 2006; 129(Pt 5):1201-17.
PMC: 3508431.
DOI: 10.1093/brain/awl056.
View
2.
Kitamura S, Sugihara K, Ohta S
. Drug-metabolizing ability of molybdenum hydroxylases. Drug Metab Pharmacokinet. 2006; 21(2):83-98.
DOI: 10.2133/dmpk.21.83.
View
3.
Topcu M, Coskun T, Haliloglu G, Saatci I
. Molybdenum cofactor deficiency: report of three cases presenting as hypoxic-ischemic encephalopathy. J Child Neurol. 2001; 16(4):264-70.
DOI: 10.1177/088307380101600406.
View
4.
Ronnefarth G, Misselwitz J
. Nephrocalcinosis in children: a retrospective survey. Members of the Arbeitsgemeinschaft für pädiatrische Nephrologie. Pediatr Nephrol. 2000; 14(10-11):1016-21.
DOI: 10.1007/s004670050065.
View
5.
Schwahn B, van Spronsen F, Belaidi A, Bowhay S, Christodoulou J, Derks T
. Efficacy and safety of cyclic pyranopterin monophosphate substitution in severe molybdenum cofactor deficiency type A: a prospective cohort study. Lancet. 2015; 386(10007):1955-1963.
DOI: 10.1016/S0140-6736(15)00124-5.
View